Jean-Paul Kress is President, Chief Executive Officer and Chairman of Vor Biopharma Inc. (VOR). The company reported total compensation of $65,027,569 for fiscal year 2025.
| Salary | $344,615 |
|---|---|
| Bonus | $400,000 |
| Stock awards | $0 |
| Option awards | $64,013,465 |
| Non-equity incentive plan | $251,425 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $18,064 |
| Total | $65,027,569 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Vor Biopharma Inc. filed April 27, 2026, accession 0001193125-26-181883.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Jean-Paul Kress this page | President, Chief Executive Officer and Chairman | $65,027,569 |
| Sandesh Mahatme | Chief Financial Officer | $39,406,098 |
| Qing Zuraw | Former Chief Development Officer | $11,837,193 |
| Robert Ang | Former President and Chief Executive Officer | $3,364,395 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Vor Biopharma Inc. compensation brief.
Jean-Paul Kress's compensation sits inside Vor Biopharma Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.